Combined introduction of anti-IL2 receptor antibodies, mycophenolic acid and tacrolimus: effect on malignancies after renal transplantation in a single-centre retrospective cohort study

HLA Mismatches Remain Risk Factors for Acute Kidney Allograft Rejection in Patients Receiving Quadruple Immunosuppression With Anti-Interleukin-2 Receptor Antibodies

(2016) Karl M. Wissing et al.   TRANSPLANTATION

Switch to a Sirolimus-Based Immunosuppression in Long-Term Renal Transplant Recipients: Reduced Rate of (Pre-)Malignancies and Nonmelanoma Skin Cancer in a Prospective, Randomized, Assessor-Blinded, Controlled Clinical Trial

(2010) R. Salgo et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Incidence and Clinical Predictors of a Subsequent Nonmelanoma Skin Cancer in Solid Organ Transplant Recipients With a First Nonmelanoma Skin Cancer

(2010) Gianpaolo Tessari et al.   ARCHIVES OF DERMATOLOGY

Minimizing the Risk of Posttransplant Malignancy

(2010) Josep M. Campistol   TRANSPLANTATION

Aggressive Behavior of Nonmelanotic Skin Cancers in Solid Organ Transplant Recipients

(2010) David G. Lott et al.   TRANSPLANTATION

First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients

(2009) K. A. Mackenzie et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial

(2009) Francesco P. Schena et al.   TRANSPLANTATION

Late Onset of Bladder Urothelial Carcinoma After Kidney Transplantation for End-Stage Aristolochic Acid Nephropathy: A Case Series With 15-Year Follow-up

(2008) Anne Lemy et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

BK Virus Nephritis after Renal Transplantation

(2008) A. Dall et al.   Clinical Journal of the American Society of Nephrology